CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $13,132,000 | -44.0% | 193,117 | -32.1% | 0.04% | -45.6% |
| Q3 2017 | $23,448,000 | -56.8% | 284,565 | -50.9% | 0.07% | -57.8% |
| Q2 2017 | $54,249,000 | +41.0% | 579,397 | -4.1% | 0.16% | +40.0% |
| Q1 2017 | $38,466,000 | +334.3% | 604,157 | +203.0% | 0.12% | +325.9% |
| Q4 2016 | $8,856,000 | +89.2% | 199,373 | +53.5% | 0.03% | +92.9% |
| Q3 2016 | $4,681,000 | -78.2% | 129,854 | -44.4% | 0.01% | -78.5% |
| Q3 2015 | $21,470,000 | -70.0% | 233,469 | -71.3% | 0.06% | -65.6% |
| Q2 2015 | $71,546,000 | +68.8% | 814,128 | +42.6% | 0.19% | +76.6% |
| Q1 2015 | $42,391,000 | +36.5% | 571,080 | +3.0% | 0.11% | +35.4% |
| Q4 2014 | $31,046,000 | +204.4% | 554,395 | +125.1% | 0.08% | +558.3% |
| Q2 2014 | $10,200,000 | +0.2% | 246,306 | +67.7% | 0.01% | -47.8% |
| Q1 2014 | $10,175,000 | -57.1% | 146,890 | -62.7% | 0.02% | -56.6% |
| Q4 2013 | $23,726,000 | +30.2% | 393,659 | +31.3% | 0.05% | +26.2% |
| Q3 2013 | $18,221,000 | -17.4% | 299,794 | -9.0% | 0.04% | -17.6% |
| Q2 2013 | $22,066,000 | – | 329,441 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |